Insulet | PODD - Net Income


Insulet reported $101.6M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Align Technology USD 135.76M 79.01M Dec/2025
AtriCure USD 1.76M 2.02M Dec/2025
Avanos Medical USD -1.3M 100K Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 672M 83M Dec/2025
Cardinal Health USD 467M 17M Dec/2025
Cooper Companies USD 84.6M 13.7M Sep/2025
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 91.2M 199.9M Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Globus Medical USD 118.97M 83.88M Sep/2025
ICU Medical USD -15.73M 12.34M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
J&J USD 5.12B 36M Dec/2025
Masimo USD -100.4M 151.7M Sep/2025
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Solventum Corp USD 1.27B 1.18B Sep/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -408.89M 531.47M Sep/2025
West Pharmaceutical Services USD 132.1M 7.9M Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025